Christian v. Altaire Pharmaceuticals, Inc.

District Court, E.D. Kentucky·Decided November 25, 2020·No. 5:20-cv-00306·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF KENTUCKY CENTRAL DIVISION (at Lexington)

LUCINDA CHRISTIAN, ) ) Plaintiff, ) Civil Action No. 5: 20-306-DCR ) V. ) ) ALTAIRE PHARMACEUTICALS, INC., ) MEMORANDUM OPINION et al., ) AND ORDER ) Defendants. )

*** *** *** *** Plaintiff Lucinda Christian has moved the Court to reconsider its October 13, 2020, Memorandum Opinion and Order denying leave to file a Second Amended Complaint and granting defendants’ motions to dismiss. [Record No. 22] In doing so, she repeatedly attempts to bend the facts in the record and the Federal Rules of Civil Procedure to fit her interests. Because neither are so flexible, her motion will be denied. Additionally, Defendants Amazon Retail, LLC, and Amazon.com Services, LLC’s1 uncontested motion for judgment on the pleadings [Record No. 24] will be granted. I. Christian brought this products liability action against Altaire Pharmaceuticals, Inc. (“Altaire”) and Amazon in state court, alleging that ActivEyes Nighttime Lubricant Eye Ointment caused her permanent eye injury. Amazon removed the action to this Court and filed a motion to dismiss. [Record Nos. 1, 5] Christian was then given the opportunity to file her

1 These defendants will be referred to collectively as “Amazon.”

First Amended Complaint. [Record Nos. 12, 13] Altaire and Amazon responded with motions to dismiss, and Christian then submitted a motion for leave to file a Second Amended Complaint. [Record Nos. 15, 16, 17]

The Court denied Christian’s motion for leave to amend, finding that her proposed complaint could not survive a Rule 12(b)(6) motion to dismiss. [Record No. 20] For the same reasons, it granted Altaire and Amazon’s motions to dismiss. [Id.] The Memorandum Opinion and Order left one claim pending: Christian’s strict liability claim against Amazon. Christian has now filed a motion to reconsider the dismissal of her claims against Altaire and the denial of leave to amend.2 [Record No. 22] Beyond a cursory reference to “F.R.C.P. 59 and/or 60” in her reply brief [Record No.

29, p. 1], Christian has not indicated what standard applies to her motions. Altaire and Amazon, however, suggest treating her filing as a motion under Rule 59(e) or Rule 60(b) of the Federal Rules of Civil Procedure. [Record Nos. 27, 28] Because it left “unresolved pending claims,” the Court’s October 13, 2020, Memorandum Opinion and Order was not a “final order or judgment.” Simmerman v. Ace Bayou Corp., 304 F.R.D. 516, 518 (E.D. Ky. 2015) (citing Davey v. St. John Health, 297 F. App’x 466, 469 (6th Cir. 2008)). Accordingly, neither Rule 59(e) nor Rule 60(b) “provides an appropriate means to challenge” the Court’s

determinations. Id.

2 Christian has styled her motion as a “Renewed Motion to File Second Amended Complaint.” [Record No. 22] However, it consists of four sentences, which in substance ask the Court to reconsider its previous ruling. Accordingly, it will be evaluated as a motion for reconsideration.

Rather, Christian’s motion must be construed as one brought under Rule 54(b), which gives district courts the “inherent authority . . . to reconsider interlocutory orders and re-open any part of a case prior to the entry of final judgment.” Id. (citing Rodriguez v. Tenn. Laborers

Health & Welfare Fund, 89 F. App’x 949, 959 (6th Cir. 2004); Mallory v. Eyrich, 922 F.2d 1273, 1282 (6th Cir. 1991)). Under Rule 54(b), reconsideration is appropriate only if “there is (1) an intervening change of controlling law; (2) new evidence available; or (3) a need to correct a clear error or prevent manifest injustice.” Rodriguez, 89 F. App’x at 959. Christian’s original motion does not argue that any of the factors supporting reconsideration apply. Instead, it reiterates facts and arguments from prior filings and devotes significant space to a Warning Letter from the Federal Drug Administration (“FDA”). [Record

No. 22, pp. 2–4] That letter, dated March 12, 2020, addresses an inspection that took place from March 25 to April 19, 2019. [Record No. 22-1] In reply, after being confronted with caselaw regarding motions for reconsideration, Christian notes that these records are “newly discovered evidence and the substance thereof justifies relief from the dismissal.” [Record No. 29, p. 2] In support, Christian asserts that the Court “did its own investigation,” [Record No. 29, p. 2] and “performed a deeper analysis into the public record,” [Record No. 22, p. 2] which in turn allows her to do the same.

Christian is mistaken on multiple fronts. First, she overstates the Court’s consideration of the actual text of the relevant voluntary recall notice. The Court took judicial notice of that record for one reason: it directly contradicted Christian’s pleadings. Christian’s proposed Second Amended Complaint includes an inaccurate date and exaggerates the actual content of the notice. [See Record 1-3, ¶ 6.] That places Christian in a precarious position because, when

a party misrepresents relevant facts, the Court need not accept them as true. Morgan v. Church’s Fried Chicken, 829 F.2d 10, 12 (6th Cir. 1987). Here, the Court was forced to look outside Christian’s pleadings to reach a ruling that was fair to all parties. Rather than

“welcome[] that analysis,” [Record No. 22, p. 2], Christian should consider making truthful representations in the first instance. Second, this Court’s reliance on the actual FDA notice does not offer any support for Christian’s motion for reconsideration. Christian must show that reconsideration is appropriate because there is “new evidence available.” Rodriguez, 89 F. App’x at 959. However, she does not argue that the evidence she cites was unavailable to her prior to the Court’s ruling. Unfortunately for Christian, the fact that counsel only recently performed

“further analysis” of FDA records [Record No. 29, p. 2], does not mean the March 12, 2020, warning letter is newly available evidence. This information does not warrant reconsideration under Rule 54(b). Christian’s request for reconsideration of the denial of leave to amend is also without merit. For the third time, Christian asks the Court to allow her to amend her Complaint for one reason: her action was originally brought in state court. According to her, she “has not yet been afforded the opportunity to amend her Complaint,” and her proposed “Second Amended

Complaint would be the first filed in this federal court.” [Record No. 29, p. 3] Therefore, she argues, the Court must allow her to bring her pleadings into compliance with federal pleading standards. [Id.]

This is a false statement.3 Christian was given the opportunity to amend her Complaint after removal. [Record Nos. 12, 13] But when both her amended Complaint and her proposed Second Amended Complaint failed to comply with federal pleading standards, she was denied

leave to amend and claims were appropriately dismissed. [Record No. 20] Now, rather than offering reasons for the Court to reconsider its ruling on her motion for leave to amend, Christian relies exclusively on falsehoods and previously rejected arguments. In addition to the continued futility of amendment, Christian has shown both “bad faith” and “repeated failures to cure deficiencies.” Forman v. Davis, 371 U.S. 178, 182 (1962).

Free access — add to your briefcase to read the full text and ask questions with AI

Christian v. Altaire Pharmaceuticals, Inc., (E.D. Ky. 2020).

Christian v. Altaire Pharmaceuticals, Inc. (Christian v. Altaire Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Carolyn Morgan v. Church's Fried Chicken
829 F.2d 10 (Sixth Circuit, 1987)
Davey Ex Rel. Johnston v. St. John Health
297 F. App'x 466 (Sixth Circuit, 2008)
Bosch v. Bayer Healthcare Pharmaceuticals, Inc.
13 F. Supp. 3d 730 (W.D. Kentucky, 2014)
Rodriguez v. Tennessee Laborers Health & Welfare Fund
89 F. App'x 949 (Sixth Circuit, 2004)
Simmerman v. Ace Bayou Corp.
304 F.R.D. 516 (E.D. Kentucky, 2015)
Mallory v. Eyrich
922 F.2d 1273 (Sixth Circuit, 1991)